TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IMMX

Immix Biopharma Inc

Healthcare · Biotechnology

12.80$ +2.9% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMMX
Line item 2019 2020 2021 2022 2023 2024 2025
-42.8% +3,271.4% -18.1% +33.7% +15.2% +356.9%
-43.0% +3,317.0% -18.1% +32.8% +2.1% +401.2%
-46.7% +4,411.7% -23.8% +30.3% +1.0% +431.2%
-46.7% +4,411.7% -23.8% +30.3% +1.0% +467.9%
-27.5% -79.8% +894.1% +358.4% +68.4%
-24.0% -22.6% -37.5%
+14.8% -96.2% +765.3% +112.9% +160.5% +13.9%
+14.8% -96.2% +530.2% +192.3% +133.4% +16.4%
+0.0% -98.8% +113.6%
+1.9% -43.4% +0.1% +901.6% +276.0% +1.0%
-26.8% +24.7% -19.2% +607.8%
+130.3% -52.8% +278.1% +24.9% +63.1% +16.5%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?